Press release
Masimo Reports First Quarter 2025 Results
IRVINE, Calif.--(BUSINESS WIRE)-- Masimo Corporation (Nasdaq: MASI) today announced its financial results for the first quarter ended March 29, 2025. First

About this update from Masimo Corporation
[{"type":"text","content":" IRVINE, Calif.--(BUSINESS WIRE)--\nMasimo Corporation (Nasdaq: MASI) today announced its financial results for the first quarter ended March 29, 2025.\n\nFirst Quarter 2025 Results From Continuing Operations(1):\n\n\nGAAP revenue of $372 million, representing 10% on a reported basis;\n\n\nNon-GAAP revenue of $371 million, representing 10% on a constant currency basis(3);\n\n\nGAAP net income per diluted of $0.86; and\n\n\nNon-GAAP net income per diluted share(3) of $1.36, which grew 56% versus prior year period.\n\n\nFirst Quarter 2025 Results From Discontinued Operations(2):\n\n\nGAAP loss from discontinued operations, net of tax was ($218) million, which included an impairment of intangibles of $295 million for the non-healthcare consumer business.\n\n\nKatie Szyman, Chief Executive Officer of Masimo, said, “Since joining Masimo as CEO three months ago, I have been focused on immersing myself in our business. I have visited customers, employees, manufacturing and R&D sites, evaluated our innovation pipeline, and attended national meetings with our sales team. My key takeaways are that our technology advantage is real, we have a stellar team that is enthusiastic about the path forward at Masimo, and we have an opportunity to build and improve from a position of meaningful strength. Our first quarter results clearly demonstrate the earnings power of our core business as we delivered double-digit revenue growth and exceptional earnings growth.”\n\n2025 Outlook For Continuing Operations(4):\n\n\nNon-GAAP revenue of $1,500 to $1,530 million, increasing 8% to 11% on a constant currency basis(3);\n\n\nExcluding the impact of new tariffs (for comparison purposes only to prior guidance, which excluded new tariffs):\n\n\nNon-GAAP operating profit of $420 to $436 million;\n\n\nNon-GAAP operating margin of 28.0% to 28.5%; and\n\n\nNon-GAAP earnings per diluted share of $5.30 to $5.60.\n\n\nUpdated guidance now includes the impact of new tariffs before any mitigation:\n\n\nNon-GAAP operating profit of $383 to $403 million;\n\n\nNon-GAAP operating margin of 25.5% to 26.4%; and\n\n\nNon-GAAP earnings per diluted share of $4.80 to $5.15.\n\n\nWe have developed a number of mitigation plans and will continue to reassess and modify our plans as the situation merits. These plans include adjusting our product sourcing and operations to mitigate s...